Akynzeo

Akynzeo is a combination medication containing palonosetron and fosnetupitant, designed for intravenous use. It is commonly used to prevent nausea and vomiting caused by chemotherapy. This medication is manufactured by Helsinn Birex Pharmaceuticals Limited and is available in the EU.

Akynzeo is primarily used to prevent nausea and vomiting in patients undergoing chemotherapy. The combination of palonosetron and fosnetupitant works to target different receptors in the body, providing comprehensive relief. This medication is often prescribed to patients who are undergoing chemotherapy treatments that are known to cause severe nausea and vomiting.

Akynzeo may cause common side effects such as fatigue, headache, and constipation. Some patients may also experience dizziness or abdominal pain. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Akynzeo should be used with caution in patients with a history of heart conditions or electrolyte imbalances. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the prescribed dosage and administration instructions provided by your healthcare professional.

Akynzeo may interact with other medications, including those that affect the heart rhythm or are metabolized by the liver. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Additionally, alcohol should be avoided while taking Akynzeo, as it may increase the risk of side effects.